. Author manuscript; available in PMC: 2011 Dec 1.

Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Oct 11;19(12):3027–3036. doi: 10.1158/1055-9965.EPI-10-0486

Table 3.

Longitudinal analysis comparing mean yearly average HbA1c levels among case groups with any adenoma or advanced adenoma versus controls without any adenoma.

	Study 1 – Adenoma anywhere in the colon			Study 2 – Distal Adenoma
	No Adenoma	Advanced Adenoma	Any Adenoma	No Adenoma	Advanced Adenoma	Any Adenoma
N	2,952	478	1,296	8,862	289	951
Mean Estimate^* (SE) (%)	8.20 (0.026)	8.28 (0.057)	8.26 (0.036)	8.32 (0.016)	8.42 (0.079)	8.37 (0.044)
Difference in mean estimates^** (95% CI, p) (%)	Reference	0.07 (-0.04 to 0.19, p=0.24)	0.06 (-0.02 to 0.14, p=0.16)	Reference	0.09 (-0.06 to 0.25, p=0.24)	0.05 (-0.04 to 0.14, p=0.25)

SE = Standard error

Least Squares Means adjusted for sex, age, ethnicity, BMI, income status, duration of diabetes, NSAID use, aspirin use, statin use and use of acid suppressive medications.

^**

Based on longitudinal analysis adjusted for sex, age, ethnicity, BMI, income status, duration of diabetes, NSAID use, aspirin use, statin use and use of acid suppressive medications.